Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
I arrived late so I am well under water, and you know what, there is no way I am giving away my £25k of shares the compounds are worth a lot more than 6.6p
There is no volume to justify 4.4% drop so I will continue to hold into sensible money
Are GSK having problems ?
https://endpts.com/one-of-glaxosmithklines-top-cancer-drug-prospects-goes-down-in-3rd-straight-setback-leaving-a-4b-deal-on-life-support/
Buys 12.3m
Sells. 6.5 m
SP drops 6.5 % really? That doesn’t seem right
Interesting the buys are mainly large and the sell are much smaller
I fear stop losses which should not have been set have been triggered
Smaller Pi investors loosing out
Larger investors moving in at a low price
Hold tight guys still a bumpy ride with lots of manipulation to take your shares this is not a
“Robin Hood” story
Take care ........
Berm,
Thanks for clarifying the Moditope delivery with Amplivant
If a simple injection is all that is required how many more months will we have to wait to get a simple Phase 1 to start to prove safety
After years of scientific lab work, then recent solid financial support additional staff and management we are in danger of failure due to not having the ability to carry out the test in humans
Could be great science but show me the results. The world won’t wait for Scancell
AIMO. Take care. .......
As we anticipate news of progress in RSA
Other companies are being acquired by big pharma.
https://www.merck.com/news/merck-to-acquire-pandion-therapeutics/
Keep the focus team Scancell ,progress sooon as possible
Good luck LTH
AA I held GWP shares and unfortunately sold out too early before it got bought out. I was of the opinion bought out went onto Nasdaq and has continued to rise in value. So tell me what happened that concerned you ?
The RNS today was to update development with Sierra Oncology Inc. This update was a US investor update which resulted in Sierra Oncology Inc SP to increase by 3.88%
So What’s not to like.
We have just seen stop / loss triggered by inexperienced investors who need to take stop loss off their settings
Take care ..........
Bill your spot on
Lets see the clinical trials start
And the data results published then we can say we have started
Until then nobody is interested.
A message which Lindy fully understands and she will move with process and speed to rectify the lost time.
Take care ......
We can only speculate as to why CH has lost his job. Possible his autocratic old school management style just wasn’t working. After3 years with no progress to get one PH 1 clinical study in process I feel he may have exasperated his management team.
We probably will never find out what happened to ignite the speedy decision to remove him, but it’s done.
Professor Lindy Durrant CEO Scancell is the only choice for the position and I think the best choice to address CH’s departure.
In the near term this is going to be tough to juggle the increased work load but may also alleviate the frustration which has been building due to lack of commercial progress in clinical trials.
We usher in a new, and very competent CEO
Professor Lindy Durrant
She invented the science and is more than capable to explain the science in high level scientific terminology. But equally, and perhaps more importantly can explain the benefits the science brings to audiences who are looking how the science can deliver a cure to cancer sufferers and vaccines that could fight covid variants .
Her management style is very enthusiastic warm and engaging which will change the dynamics of Scancell in a very positive way.
(All IMO)
Presentations25 Feb 2021 19:00
Message to inspire new investor to the fact we have Covidity for C19 and loads of other advanced products in cancer vaccines
May have been the desired objective
However, the overly technical presentation would have done nothing to excited investors hoping for news of a second generation vaccine.
Cliff the most boring presenter, needed to delivery a positive update told in simple English so new investors knew what a fantastic scientific organisation they had invested in. Suggest Lindy does a simple presentations on what these new vaccines will do for cancer sufferers in her enthusiastic stile and let Cliff do the slipping start date ( I though Q1 then Q2 2021 now looks like 2022 )”
I think CH stayed to long, so I think
Lindy will hold the reigns until Redmile can get a Bio savvy CEO to take this fantastic pipeline forward.